“The strain can strengthen the virus and enable it bypass the body’s immune system,” said Warwick University virologist and oncology professor Lawrence Young in the United Kingdom.
“The E484K mutation can weaken the body’s immune system. This is potentially worse if an individual who [previously contracted Covid-19] contracted the virus again.”
The BMJ medical journal reported Novavax’s Covid-19 vaccine is only 60 percent effective against the Eek virus. The findings on E484K prompted the AstraZeneca pharmaceutical company to redesign its Covid-19 vaccine.
(Penulis : Haryanti Puspa Sari, Dian Erika Nugraheny, Sekar Langit Nariswari
Editor : Icha Rastika, Kristian Erdianto, Glori K. Wadrianto)
Sources:
Simak breaking news dan berita pilihan kami langsung di ponselmu. Pilih saluran andalanmu akses berita Kompas.com WhatsApp Channel : https://www.whatsapp.com/channel/0029VaFPbedBPzjZrk13HO3D. Pastikan kamu sudah install aplikasi WhatsApp ya.